Skip to main content
. 2017 Jul 29;58(7):466–476. doi: 10.1002/em.22110

Table 1.

Summary of ACB‐PCR MF Measurements

Sample type Gene mutation Tissue Median MF Geomean MF No. samples >10−5 No. samples <10−5 Mutation positive samples (%)
Normal PIK3CA H1047R Colon 1.57 × 10−5 1.98 × 10−5 20 0 100
PIK3CA H1047R Lung 2.45 × 10−5 3.96 × 10−5 19 0 100
PIK3CA E545K Breast 6.06 × 10−6 1.78 × 10−5 4 6 40
PIK3CA E545K Colon 2.67 × 10−6 2.69 × 10−6 0 20 0
PIK3CA E545K Lung 5.35 × 10−6 6.75 × 10−6 3 16 16
PIK3CA E545K Thyroid 6.52 × 10−6 7.02 × 10−6 5 14 26
KRAS G12D Colon 2.88 × 10−5 4.90 × 10−5 15 0 100
KRAS G12V Colon 7.66 × 10−6 1.08 × 10−5 6 9 40
Adenoma PIK3CA H1047R Colon 1.73 × 10−5 4.56 × 10−5 8 1 89
PIK3CA E545K Colon 2.15 × 10−6 2.38 × 10−6 2 6 25
Carcinoma PIK3CA H1047R Colon 1.63 × 10−5 3.46 × 10−5 19 1 95
PIK3CA H1047R Lung 2.54 × 10−5 3.48 × 10−5 24 0 100
PIK3CA E545K Breast 3.92 × 10−5 8.36 × 10−5 7 2 78
PIK3CA E545K Colon 3.07 × 10−6 7.89 × 10−6 3 17 15
PIK3CA E545K Lung 4.17 × 10−6 7.13 × 10−6 4 20 8
PIK3CA E545K Thyroid 8.39 × 10−6 8.78 × 10−6 7 11 39

The median and geomean MFs shown in italics are below the limit of accurate ACB‐PCR quantification (10−5).